Register to receive a free European Markets for Diabetes Monitoring, Treatment and Drug Delivery report synopsis and brochure
Diabetes mellitus, commonly referred to as diabetes, is a chronic disease that is characterized by defects in insulin production or usage, or a combination of the two, and affects approximately 415 million people worldwide.1 The European market for diabetes monitoring, treatment, and drug delivery currently is undergoing significant changes in response to technological innovation, pricing pressure, and an expanding competitive landscape. The major segments affected by these changes are insulin pumps, continuous glucose monitoring (CGM), blood glucose test strips, and insulin pen needles.
Increasing Demand For Insulin Pump Therapy And CGM
Diabetic patients are transitioning from traditional medical devices, such as blood glucose meters, insulin pens, and syringes, towards modern products that offer less-invasive solutions and inter-device communication. Included in this category of less-invasive products are the CGM and insulin pump segments, which are experiencing particularly high growth in Europe.
Read more at Med Device Online
For Further Information
More on the diabetes market in Europe can be found in a report suite published by iData Research entitled the European Markets for Diabetes Monitoring, Treatment and Drug Delivery.